2 min readResearchers Find that Regulating Lipid Metabolism in Neurons Helps Axon Regeneration

Hong Kong, China — Typical examples include paralysis due to a spinal cord injury and visual field atrophy or even complete blindness due to optic nerve atrophy in glaucoma patients. Therefore, in-depth study of the basic biological processes that affect axon regeneration is particularly important for human health. Traditional research on axon regeneration has focused on the cytoskeleton, with a few studies exploring cell membranes. However, because the nervous system is rich in lipids, and the axon regeneration process requires a large amount of lipids to participate in the formation of cell membranes, related research is of great significance. The role of neuronal lipid metabolism on axon regeneration is a mystery that is still waiting to be solved.

The latest study by Prof. LIU Kai, Cheng Associate Professor at The Hong Kong University of Science and Technology’s Division of Life Science, started from the direction of lipid metabolism. For the first time, it was found that regulating the glycerolipid metabolism of neurons can promote the regeneration of axons of central neurons after injury.

Researchers first knocked down key genes that are involved in fatty acid metabolism, cholesterol synthesis, and the glycerol phosphate pathway in dorsal root ganglion (DRG) neurons, which were cultured in vitro. After item-by-item testing, it was found that knocking down a gene called lipin1 can significantly promote DRG neurite growth. This indicates that lipid metabolism in neurons has an important effect on the axon regeneration process.

Lipin1 is a key enzyme of the glycerol phosphate pathway because it can catalyze the conversion of phosphatidic acid to diglyceride, which is a substrate for the synthesis of various phospholipids and triglycerides. Triglycerides are the main energy storage substance in mammals, and phospholipids containing phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are the main components of cell membranes.

Lipin1 has two main functions: participating in the synthesis of diglycerides and regulating gene expression in the nucleus. To determine which function is related to axon regeneration, researchers have overexpressed the lipin1 gene with a phosphatase function mutation and nuclear localization sequence deletion in the retinal ganglion cells with lipin1 depletion. They found that its phosphatase function is the main factor affecting axon regeneration.

Researchers also tested the effects of lipin1 elimination on neuronal lipid metabolism to explore which components affect axon regeneration. Their measurements showed the following: cholesterol and fatty acid content in neurons did not change significantly after lipin1 elimination; triglyceride content was significantly reduced; and the PC and PE levels had significantly increased. This suggests that lipin1 may cause neurons to synthesize triglycerides rather than phospholipids. What effect do triglycerides and phospholipids have on axon regeneration? Experiments have revealed that skewing glycerolipid metabolism toward storage triglycerides impedes axon regrowth in injured neurons, while directing it toward phospholipid synthesis promotes the axon regeneration. Therefore, the inhibition of triglyceride synthesis or an increase in phospholipid synthesis can promote axonal regeneration.

The current state of this research was aptly summarized by Professor Liu: “This research provides a new direction for the study of the axon regeneration in the central nervous system. The results provide a new explanation for the difference between the regeneration capacity of the central and peripheral nervous systems, and it may provide new translational targets for CNS injury.”

Article adapted from a Hong Kong University of Science and Technology news release.

Publication: Rewiring Neuronal Glycerolipid Metabolism Determines the Extent of Axon Regeneration. Yang, C et al. Neuron (November 27, 2019): Click here to view.

Axon, lipid metabolism, lipin1

Leave a Reply

© Mindzilla. All rights reserved.